Chronic Pelvic Pain Treatment Market Outlook 2031

  • The global chronic pelvic pain treatment market was valued at US$ 5.7 Bn in 2021
  • The market is projected to grow at a CAGR of 3.6% from 2022 to 2031
  • The global chronic pelvic pain treatment market is anticipated to reach more than US$ 8 Bn by the end of 2031

Analysts’ Viewpoint on Chronic Pelvic Pain Treatment Market Scenario

The global chronic pelvic pain treatment market has been witnessing moderate growth since the last few years. This trend is expected to continue during the forecast period. Chronic pelvic pain is caused primarily due to surgery near the pelvic region, cancer (ovarian, uterus, etc.), and pregnancy complications. Demand for various treatments and medications that can reduce pelvic pain has been rising across the globe. Growth in adoption of new treatment procedures such as acupuncture, chiropractic care, biofeedback therapy, and behavioral therapy is projected to drive the global chronic pelvic pain treatment market. Health camps and other government strategies & initiatives to spread awareness about treatments for pelvic pain are also augmenting the market.

chronic pelvic pain market

Overview of Chronic Pelvic Pain Treatment Market

Pelvic pain occurs in the pelvic region (the pelvic bone or reproductive organs) in females or males. It is termed chronic when it lasts for six months or more. According to the European Association of Urology (EAU), chronic or persistent pain in structures related to the pelvis of either men or women is termed pelvic pain. Chronic pelvic pain is often associated with behavioral, negative cognitive, and emotional consequences as well as with symptoms indicative of lower urinary tract, pelvic floor, or gynecological dysfunction. Various endoscopic devices are being introduced in the market for accurate diagnosis of chronic pelvic pain. Effective management of chronic pelvic pain care and treatment in healthcare centers is expected to create significant opportunities for market players.

Request a sample to get extensive insights into the Chronic Pelvic Pain Treatment

Rise in Awareness about Treatment for Chronic Pelvic Pain to Drive Global Market

Chronic pelvic pain frequently coexists with non-pelvic pain disorders (e.g. fibromyalgia and migraines) and non-pain comorbidities (e.g. sleep, mood, and cognitive impairment) leading to severe pain and disability. For instance, 50% to 90% of patients with chronic pelvic pain experience musculoskeletal pain and dysfunction. Changes in lifestyle, consumption of hybrid food, increase in pollution, stress, anxiety, and depression could lead to diseases that cause pelvic pain, especially in women. Delay in receiving chronic pelvic pain treatment causes unnecessary suffering from a condition that could be improved with proper management. Rise in awareness about chronic pelvic pain causes and treatment is likely to create growth opportunities for market players.

Easy Access, Cost-effectiveness, and Quick-relief Medications Augmenting Global Market

In terms of treatment, the global chronic pelvic pain treatment market has been classified into medications, surgery, and others. The medications segment has been split into pain relievers, hormone treatments, antibiotics, and antidepressants. The medications segment dominated the global chronic pelvic pain treatment market with around 70% in 2021. The trend is projected to continue during the forecast period. Rise in awareness about the availability of medications for pain management is driving consumption and acceptance of pain management drugs over other treatment options. Medications are the first and primary treatment options provided to patients suffering from chronic pelvic pain. OTC pain relievers are one of the most commonly used drugs in the world. NSAIDs and some other non-opioids such as paracetamol, codeine, ibuprofen, and Aspirin (acetylsalicylic acid) are the most consumed drugs across the globe. According to the FDA, nearly eight in 10 prescriptions filled in the U.S. are for generic drugs. Hence, rise in usage of generic drugs for chronic pelvic pain is expected to drive the market for chronic pelvic pain treatment in the next few years.

Request a custom report on Chronic Pelvic Pain Treatment

Growth in Preference for OTC Painkillers and Other Medications to Boost Retail Pharmacies & Drug Stores Segment

Based on distribution channel, the global chronic pelvic pain treatment market has been divided into retail pharmacies & drug stores, e-commerce, and others. The retail pharmacies & drug stores segment held major share of around 65% in 2021. Growth of the segment can be ascribed to the increase in preference for over-the-counter painkillers and other medications in pharmacies and drug stores.

Regional Outlook of Global Chronic Pelvic Pain Treatment Market

North America accounted for the largest share of around 36% of the global market in 2021, owing to the increase in incidence of chronic pelvic pain in the region. According to the NCBI, one in seven women in the U.S. suffers from chronic pelvic pain. Europe held around 31% share of the global market in 2021. The market in the region is growing at a rapid pace due to the rise in awareness about treatments and increase in number of complete body check-ups. This can help people identify the cause of chronic pelvic pain and avail the correct treatment. Asia Pacific accounted for a larger share of the market than Latin America and Middle East & Africa in 2021. However, the market in Latin America is anticipated to grow at a faster CAGR than that in Middle East & Africa during the forecast period.

Analysis of Key Players in Chronic Pelvic Pain Treatment Market

The chronic pelvic pain treatment market report concludes with the company profiles section, which includes key information about the leading players in the global chronic pelvic pain treatment market. Leading players in the global chronic pelvic pain treatment market include Bayer AG, Becton, Dickinson and Company, GlaxoSmithKline plc, Hospiinz, Intuitive Surgical, MAST PAK SURGICAL CORP, Mayne Pharma Group Limited, Medtronic, and Perrigo Company plc.

Key Developments in Global Chronic Pelvic Pain Treatment Market

  • According to the National Institutes of Health (NIH), duloxetine, an FDA-approved drug for other pain treatments, is under clinical trial to check its effectiveness in treating chronic pelvic pain in women
  • In February 2020, Baxter International, Inc. announced that it had completed the acquisition of the Seprafilm adhesion barrier and other related assets from Sanofi. Seprafilm is an adhesion barrier that reduces the severity of adhesions following abdominopelvic surgery.

Each of these players has been profiled in the chronic pelvic pain treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Chronic Pelvic Pain Treatment Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 5.7 Bn

Market Forecast Value in 2031

More than US$ 8 Bn

Growth Rate

(CAGR)

3.6%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Technology
    • Medications
      • Pain Relievers
      • Hormone Treatments
      • Antibiotics
      • Antidepressants
    • Surgery
      • Laparoscopic Surgery
      • Hysterectomy
    • Others
  • Distribution Channel
    • Retail Pharmacies & Drug stores
    • E-commerce
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Bayer AG
  • Becton, Dickinson and Company
  • GlaxoSmithKline plc.
  • Hospiinz
  • Intuitive Surgical
  • MAST PAK SURGICAL CORP
  • Mayne Pharma Group Limited
  • Medtronic
  • Perrigo Company plc

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

The global chronic pelvic pain treatment market was valued at US$ 5.7 Bn in 2021.

The global chronic pelvic pain treatment market is projected to reach more than US$ 8 Bn by 2031.

The global chronic pelvic pain treatment market is anticipated to grow at a CAGR of 3.6% from 2022 to 2031.

The medications segment held more than 70% share of the global chronic pelvic pain treatment market in 2021.

North America is expected to account for major share of the global chronic pelvic pain treatment market during the forecast period.

Prominent players in the global chronic pelvic pain treatment market include Bayer AG, Becton, Dickinson and Company, and GlaxoSmithKline plc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Chronic Pelvic Pain Treatment Market

4. Market Overview

    4.1. Introduction

        4.1.1. Treatment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Chronic Pelvic Pain Treatment Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Disease Prevalence & Incidence Rate globally with key countries

    5.2. Chronic Pelvic Pain Treatment Market Overview

    5.3. Top 3 players operating in the market space

    5.4. Reimbursement Scenario by Region/globally

6. Global Chronic Pelvic Pain Treatment Market Analysis and Forecast, by Treatment

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value & Volume Forecast, by Treatment, 2017–2031

        6.3.1. Medications

            6.3.1.1. Pain Relievers

            6.3.1.2. Hormone Treatments

            6.3.1.3. Antibiotics

            6.3.1.4. Antidepressants

        6.3.2. Surgery

            6.3.2.1. Laparoscopic Surgery

            6.3.2.2. Hysterectomy

        6.3.3. Others

    6.4. Market Attractiveness Analysis, by Treatment

7. Global Chronic Pelvic Pain Treatment Market Analysis and Forecast, by Distribution Channel

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value & Volume Forecast, by Distribution Channel, 2017–2031

        7.3.1. Retail Pharmacies & Drug stores

        7.3.2. E-commerce

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Chronic Pelvic Pain Treatment Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value & Volume Forecast, by Region

        8.2.1. North America

        8.2.2. Europe/p>

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America Chronic Pelvic Pain Treatment Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value & Volume Forecast, by Treatment, 2017–2031

        9.2.1. Medications

            9.2.1.1. Pain Relievers

            9.2.1.2. Hormone Treatments

            9.2.1.3. Antibiotics

            9.2.1.4. Antidepressants

        9.2.2. Surgery

            9.2.2.1. Laparoscopic Surgery

            9.2.2.2. Hysterectomy

        9.2.3. Others

    9.3. Market Value & Volume Forecast, by Distribution Channel, 2017–2031

        9.3.1. Retail Pharmacies & Drug stores

        9.3.2. E-commerce

        9.3.3. Others

    9.4. Market Value & Volume Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Treatment

        9.5.2. By Distribution Channel

        9.5.3. By Country

10. Europe Chronic Pelvic Pain Treatment Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value & Volume Forecast, by Treatment, 2017–2031

        10.2.1. Medications

            10.2.1.1. Pain Relievers

            10.2.1.2. Hormone Treatments

            10.2.1.3. Antibiotics

            10.2.1.4. Antidepressants

        10.2.2. Surgery

            10.2.2.1. Laparoscopic Surgery

            10.2.2.2. Hysterectomy

        10.2.3. Others

    10.3. Market Value & Volume Forecast, by Distribution Channel, 2017–2031

        10.3.1. Retail Pharmacies & Drug stores

        10.3.2. E-commerce

        10.3.3. Others

    10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Treatment

        10.5.2. By Distribution Channel

        10.5.3. By Country/Sub-region

11. Asia Pacific Chronic Pelvic Pain Treatment Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value & Volume Forecast, by Treatment, 2017–2031

        11.2.1. Medications

            11.2.1.1. Pain Relievers

            11.2.1.2. Hormone Treatments

            11.2.1.3. Antibiotics

            11.2.1.4. Antidepressants

        11.2.2. Surgery

            11.2.2.1. Laparoscopic Surgery

            11.2.2.2. Hysterectomy

        11.2.3. Others

    11.3. Market Value & Volume Forecast, by Distribution Channel, 2017–2031

        11.3.1. Retail Pharmacies & Drug stores

        11.3.2. E-commerce

        11.3.3. Others

    11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Treatment

        11.5.2. By Distribution Channel

        11.5.3. By Country/Sub-region

12. Latin America Chronic Pelvic Pain Treatment Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value & Volume Forecast, by Treatment, 2017–2031

        12.2.1. Medications

            12.2.1.1. Pain Relievers

            12.2.1.2. Hormone Treatments

            12.2.1.3. Antibiotics

            12.2.1.4. Antidepressants

        12.2.2. Surgery

            12.2.2.1. Laparoscopic Surgery

            12.2.2.2. Hysterectomy

        12.2.3. Others

    12.3. Market Value & Volume Forecast, by Distribution Channel, 2017–2031

        12.3.1. Retail Pharmacies & Drug stores

        12.3.2. E-commerce

        12.3.3. Others

    12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Treatment

        12.5.2. By Distribution Channel

        12.5.3. By Country/Sub-region

13. Middle East & Africa Chronic Pelvic Pain Treatment Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value & Volume Forecast, by Treatment, 2017–2031

        13.2.1. Medications

            13.2.1.1. Pain Relievers

            13.2.1.2. Hormone Treatments

            13.2.1.3. Antibiotics

            13.2.1.4. Antidepressants

        13.2.2. Surgery

            13.2.2.1. Laparoscopic Surgery

            13.2.2.2. Hysterectomy

        13.2.3. Others

    13.3. Market Value & Volume Forecast, by Distribution Channel, 2017–2031

        13.3.1. Retail Pharmacies & Drug stores

        13.3.2. E-commerce

        13.3.3. Others

    13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Treatment

        13.5.2. By Distribution Channel

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by tier and size of companies)

    14.2. Company Profiles

        14.2.1. Bayer AG

            14.2.1.1. Company overview

            14.2.1.2. Financial overview

            14.2.1.3. Business strategies

            14.2.1.4. SWOT analysis

            14.2.1.5. Recent developments

        14.2.2. Becton, Dickinson and Company

            14.2.2.1. Company overview

            14.2.2.2. Financial overview

            14.2.2.3. Business strategies

            14.2.2.4. SWOT analysis

            14.2.2.5. Recent developments

        14.2.3. GlaxoSmithKline plc.

            14.2.3.1. Company overview

            14.2.3.2. Financial overview

            14.2.3.3. Business strategies

            14.2.3.4. SWOT analysis

            14.2.3.5. Recent developments

        14.2.4. Hospiinz

            14.2.4.1. Company overview

            14.2.4.2. Financial overview

            14.2.4.3. Business strategies

            14.2.4.4. SWOT analysis

            14.2.4.5. Recent developments

        14.2.5. Intuitive Surgical

            14.2.5.1. Company overview

            14.2.5.2. Financial overview

            14.2.5.3. Business strategies

            14.2.5.4. SWOT analysis

            14.2.5.5. Recent developments

        14.2.6. MAST PAK SURGICAL CORP

            14.2.6.1. Company overview

            14.2.6.2. Financial overview

            14.2.6.3. Business strategies

            14.2.6.4. SWOT analysis

            14.2.6.5. Recent developments

        14.2.7. Mayne Pharma Group Limited

            14.2.7.1. Company overview

            14.2.7.2. Financial overview

            14.2.7.3. Business strategies

            14.2.7.4. SWOT analysis

            14.2.7.5. Recent developments

        14.2.8. Medtronic

            14.2.8.1. Company overview

            14.2.8.2. Financial overview

            14.2.8.3. Business strategies

            14.2.8.4. SWOT analysis

            14.2.8.5. Recent developments

        14.2.9. Perrigo Company plc

            14.2.9.1. Company overview

            14.2.9.2. Financial overview

            14.2.9.3. Business strategies

            14.2.9.4. SWOT analysis

            14.2.9.5. Recent developments

List of Tables

Table 01: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 02: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 03: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 05: North America Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 06: North America Chronic Pelvic Pain Treatment Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 07: Europe Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: Europe Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 09: Europe Chronic Pelvic Pain Treatment Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 10: Asia Pacific Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 11: Asia Pacific Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 12: Asia Pacific Chronic Pelvic Pain Treatment Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 13: Latin America Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Latin America Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 15: Latin America Chronic Pelvic Pain Treatment Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 16: Middle East and Africa Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Middle East and Africa Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 18: Middle East and Africa Chronic Pelvic Pain Treatment Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031

List of Figures

Figure 01: Global Chronic Pelvic Pain market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Chronic Pelvic Pain Treatment Market Value Share Analysis, by Treatment, 2021 and 2031

Figure 03: Global Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Treatment, 2022–2031

Figure 04: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Medications, 2017–2031

Figure 05: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

Figure 06: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Others, 2017–2031

Figure 07: Global Chronic Pelvic Pain Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 08: Global Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 09: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Retail Pharmacies & Drug stores, 2017–2031

Figure 10: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by E-commerce, 2017–2031

Figure 11: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Others, 2017–2031

Figure 12: Global Chronic Pelvic Pain Treatment Market Value Share Analysis, by Region, 2021 and 2031

Figure 13: Global Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Region, 2022–2031

Figure 14: North America Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 15: North America Chronic Pelvic Pain Treatment Market Value Share Analysis, by Country, 2021 and 2031

Figure 16: North America Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Country, 2022–2031

Figure 17: North America Chronic Pelvic Pain Treatment Market Value Share Analysis, by Treatment, 2021 and 2031

Figure 18: North America Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Treatment, 2022–2031

Figure 19: North America Chronic Pelvic Pain Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 20: North America Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 21: Europe Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 22: Europe Chronic Pelvic Pain Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 23: Europe Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 24: Europe Chronic Pelvic Pain Treatment Market Value Share Analysis, by Treatment, 2021 and 2031

Figure 25: Europe Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Treatment, 2022–2031

Figure 26: Europe Chronic Pelvic Pain Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 27: Europe Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 28: Asia Pacific Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 29: Asia Pacific Chronic Pelvic Pain Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 30: Asia Pacific Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 31: Asia Pacific Chronic Pelvic Pain Treatment Market Value Share Analysis, by Treatment, 2021 and 2031

Figure 32: Asia Pacific Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Treatment, 2022–2031

Figure 33: Asia Pacific Chronic Pelvic Pain Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 34: Asia Pacific Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 35: Latin America Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 36: Latin America Chronic Pelvic Pain Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 37: Latin America Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 38: Latin America Chronic Pelvic Pain Treatment Market Value Share Analysis, by Treatment, 2021 and 2031

Figure 39: Latin America Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Treatment, 2022–2031

Figure 40: Latin America Chronic Pelvic Pain Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 41: Latin America Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 42: Middle East and Africa Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 43: Middle East and Africa Chronic Pelvic Pain Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 44: Middle East and Africa Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 45: Middle East and Africa Chronic Pelvic Pain Treatment Market Value Share Analysis, by Treatment, 2021 and 2031

Figure 46: Middle East and Africa Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Treatment, 2022–2031

Figure 47: Middle East and Africa Chronic Pelvic Pain Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 48: Middle East and Africa Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Chronic Pelvic Pain Treatment Market